Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



3 Dow Stocks Heading Higher

After last week's QE3-fueled blast upward, the Dow Jones Industrial Average (DJINDICES: ^DJI) started this week somberly. While the Dow was down about a quarter-percent as of 1:30 p.m. EDT, not all Dow stocks were down and out.

Energy behemoth Chevron (NYSE: CVX  ) is leading the list of Dow stocks charging higher, hitting a 52-week high as oil prices continue their march upward. The stock is up 0.8% to $118.11 per share. Prices for a barrel of crude are above $100, running near four-month highs. The Federal Reserve announced plans last week to undertake another round of quantitative easing in hopes of spurring the U.S. economy. With hopes of economic stimulus and continued turmoil in the Middle East, oil prices are on the up and up, and Chevron is reaping the rewards.

Drugmakers Pfizer (NYSE: PFE  ) and Merck (NYSE: MRK  ) are both up roughly 0.6% after giving up about 2% apiece late last week. Pfizer's Inlyta recently got the nod from the European Medicines Agency, so the drug can now be prescribed for advanced renal-cell carcinoma. Every approval counts in the world of pharmaceuticals.

Telecommunications giant AT&T (NYSE: T  ) is another Dow gainer today after reporting that the iPhone 5 broke sales records over the weekend with 2 million preorders in the first 24 hours of release. The company's stock is up about 0.7% to $37.51. Apple's newest smartphone is selling faster than the 4S, and the company has warned that demand will likely exceed initial supply of the device.

Another Apple success?
As demand surges for the newest iDevice, make sure you're up to date with all the latest analysis on the tech giant. Try our premium report on Apple today. This in-depth report comes with a year of updates, so claim your investing edge today.

Fool contributor Mike Klesta owns no shares of the companies mentioned above. The Motley Fool owns shares of Apple. Motley Fool newsletter services have recommended buying shares of Apple and Chevron. Motley Fool newsletter services have recommended creating a bull call spread position in Apple. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.

Read/Post Comments (0) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2019360, ~/Articles/ArticleHandler.aspx, 10/27/2016 9:03:16 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,169.68 -29.65 -0.16%
S&P 500 2,133.04 -6.39 -0.30%
NASD 5,215.97 -34.29 -0.65%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/27/2016 4:01 PM
CVX $99.92 Down -1.27 -1.26%
Chevron CAPS Rating: ****
MRK $61.29 Up +0.42 +0.69%
Merck and Co. CAPS Rating: ****
PFE $32.48 Up +0.08 +0.25%
Pfizer CAPS Rating: ****
T $36.52 Up +0.09 +0.25%
AT and T CAPS Rating: ****